Mixed trend on the daily chart: above its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Dec 12 · inside the Ichimoku cloud · RSI 0 (oversold) · MACD above its signal · at its 52-week low
None of the 29 investors followed here reported a position in ALID in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a ALID trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for ALID.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% | ||
| 2025 | 17.6 | -2.5 | -56.4 | -13.2 | -23.4 | -11.5 | 11.0 | 0.0 | 0.0 | 0.0 | 0.0 | -95.5 | −98.5% |
| 2024 | -17.4 | -55.8 | 109.7 | 149.2 | -6.5 | -5.1 | -0.9 | -33.3 | -45.3 | 0.0 | -27.9 | -9.3 | −60.0% |
| 2023 | -0.7 | 44.1 | -33.4 | -10.0 | 49.0 | -14.3 | 12.8 | -9.4 | -29.4 | -12.7 | -39.3 | -3.4 | −59.5% |
| 2022 | 1.7 | -1.8 | -41.7 | -29.1 | 1.7 | -35.4 | 14.5 | -16.3 | -2.1 | -6.8 | -33.3 | -25.0 | −88.1% |
| 2021 | 6.7 | 23.7 | 1.0 | -11.2 | 35.1 | -12.4 | -8.6 | 11.5 | 86.9 | 3.5 | -9.2 | -5.9 | +136.0% |
| 2020 | 0.0 | -2.6 | -6.6 | 0.0 | 6.4 | 2.7 | 0.6 | 0.0 | -3.2 | -30.0 | -4.8 | -25.0 | −51.6% |
| 2019 | 15.4 | 0.0 | -1.3 | 4.7 | +19.2% |
No analyst coverage for this instrument.
Allied Corp., a cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States. The company operates in two segments, Allied Colombia and Allied Corp. It offers hemp-based CBD natural health products, as well as cannabis related products, including beauty and skincare products, and food and beverages. The company also develops ALID 10 and ALID 11 for the treatment of post-traumatic stress disorder and related mental health conditions through the targeted function of the 5-HT2 receptor and physiological pathways. Allied Corp. is headquartered in Kelowna, Canada.
No recent headlines.